Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Brooks

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Learning Health Systems|October 9, 2018
Developing a framework for integrating health equity into the learning health systemDanielle Brooks, Megan Douglas, Neelum Aggarwal, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 8, 2022
Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic ReviewDanielle Brooks, Rifka Schulman-Rosenbaum, Megan Griff, et al.
AACE Clinical Case Reports|September 15, 2021
Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin AntibodiesDanielle Brooks, Priya Grewal, Ian Baine, et al.
Diabetes Research and Clinical Practice|December 21, 2020
Characterization of hyperglycemia in patients receiving immune checkpoint inhibitors: Beyond autoimmune insulin-dependent diabetesAmanda Leiter, Emily Carroll, Danielle Brooks, et al.
Oncotarget|May 29, 2018
Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive targetDanielle Brooks, Alexandra Zimmer, Lalage Wakefield, et al.
European Journal of Endocrinology|September 23, 2021
Metabolic disease and adverse events from immune checkpoint inhibitorsAmanda Leiter, Emily Carroll, Sonia De Alwis, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|July 17, 2023
A Novel Algorithm for the Management of Inpatient COVID-19 Glucocorticoid-Induced HyperglycemiaAlexander B Karol, Natalia Viera, Selassie J Ogyaadu, et al.
The Journal of Endocrinology|November 8, 2018
Histone demethylase LSD1 deficiency and biological sex: impact on blood pressure and aldosterone productionYuefei Huang, Pei Yee Ting, Tham M Yao, et al.
Cancer Treatment and Research Communications|October 13, 2020
Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockadeKunal K Sindhu, Amanda Leiter, Erin Moshier, et al.
The Journal of Endocrinology|April 2, 2020
Striatin heterozygous mice are more sensitive to aldosterone-induced injuryAmanda E Garza, Elijah Trefts, Isis A Katayama Rangel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Learning Health Systems|October 9, 2018
Developing a framework for integrating health equity into the learning health systemDanielle Brooks, Megan Douglas, Neelum Aggarwal, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 8, 2022
Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic ReviewDanielle Brooks, Rifka Schulman-Rosenbaum, Megan Griff, et al.
AACE Clinical Case Reports|September 15, 2021
Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin AntibodiesDanielle Brooks, Priya Grewal, Ian Baine, et al.
Diabetes Research and Clinical Practice|December 21, 2020
Characterization of hyperglycemia in patients receiving immune checkpoint inhibitors: Beyond autoimmune insulin-dependent diabetesAmanda Leiter, Emily Carroll, Danielle Brooks, et al.
Oncotarget|May 29, 2018
Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive targetDanielle Brooks, Alexandra Zimmer, Lalage Wakefield, et al.
European Journal of Endocrinology|September 23, 2021
Metabolic disease and adverse events from immune checkpoint inhibitorsAmanda Leiter, Emily Carroll, Sonia De Alwis, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|July 17, 2023
A Novel Algorithm for the Management of Inpatient COVID-19 Glucocorticoid-Induced HyperglycemiaAlexander B Karol, Natalia Viera, Selassie J Ogyaadu, et al.
The Journal of Endocrinology|November 8, 2018
Histone demethylase LSD1 deficiency and biological sex: impact on blood pressure and aldosterone productionYuefei Huang, Pei Yee Ting, Tham M Yao, et al.
Cancer Treatment and Research Communications|October 13, 2020
Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockadeKunal K Sindhu, Amanda Leiter, Erin Moshier, et al.
The Journal of Endocrinology|April 2, 2020
Striatin heterozygous mice are more sensitive to aldosterone-induced injuryAmanda E Garza, Elijah Trefts, Isis A Katayama Rangel, et al.
Pageof 1